About e-Atlas

The e-Atlas is currently being upgraded and updated to provide you with an even more useful site on diabetes. It will be your one-stop source of information on diabetes: compare the latest data on diabetes prevalence and health expenditure in some 212 countries and territories; find out why people are dying from the lack of access to insulin; learn about the link between diabetes and cardiovascular disease and why the explosion in obesity prevalence is causing a parallel rise in type 2 diabetes. The e-Atlas aims to communicate the global impact of diabetes and to underline the need for intervention now.

Visit the e-atlas regularly as new features will be added to the site over the next few months.

Diabetes Atlas third edition

The newly published Diabetes Atlas, third edition, provides the very latest data on prevalence, complications, mortality and costs of care. Data from the third edition will be available on the e-atlas later this year.

Diabetes Atlas Partners

IDF would like to express its gratitude and thanks to all its partners for contributing to the Diabetes Atlas:

MerckThis version of the e-Atlas has been made possible thanks to the generous support of Merck & Co, Inc, Whitehouse Station, NJ, USA. In many countries around the world, Merck does business as MSD.

The Diabetes Atlas, second edition was produced with major support by the World Diabetes Foundation.

The Diabetes Atlas project has also received generous support from other partners:

  • Novo Nordisk
  • Novartis
  • Johnson and Johnson
  • International Diabetes Institute
  • International Obesity Task Force
  • WHO Collaborating Centre, Menzies Centre, University of Tasmania, Australia

Contributors

B Allgot, C S Cockram, G Dahlquist, L Fezeu, D Gan, K Hynes, W P T James, R Leach, J-C Mbanya, C Patterson, C Regniers, N Rigby, J Shaw, R Sicree, R Singh, G Soltèsz, R Tapp, R Williams, P Zimmet

Reproduction of material

No part of the e-Atlas may be reproduced or transmitted in any form or by any means without the prior written permission of the International Diabetes Federation. Please send all inquiries and feedback to atlas@idf.org.

Back to Top